| Ytd | -40.59% | |
| 1y | -22.08% |
| Open | 1.22 | Prev Close | 1.23 | Low | 1.19 | High | 1.23 | Mkt Cap | 105.64M |
| Vol | 305.72K | Avg Vol | 1.31M | EPS | -0.68 | P/E | -1.81 | Forward P/E | -2.15 |
| Beta | 0.97 | Short Ratio | 2.46 | Inst. Own | 57.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.36 | 200-d Avg | 1.80 | 1yr Est | 10.25 |
MIST News
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's
MONTREAL and CHARLOTTE, N. C. , July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Na
Alpha Cognition Inc. (Nasdaq: ACOG) (âAlpha Cognitionâ, or the âCompanyâ), a biopharmaceutic
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript
Milestone Pharmaceuticals Inc. remains a Strong Buy, despite recent volatility and a 37% stock decli
MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasd
The biotech fell well short of analyst projections in the first quarter.
Milestone Pharmaceuticals NASDAQ: MIST said its first quarter of 2026 marked the beginning of commer
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) reported first-quarter earnings on Wednesday before the
Milestone Pharmaceuticals (MIST) came out with a quarterly loss of $0.2 per share versus the Zacks C
MONTREAL and CHARLOTTE, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasd
MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MI
Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST - Get Free Report) have been assigned an aver
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascu
MONTREAL and CHARLOTTE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Na
MONTREAL and CHARLOTTE, N.C., April 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nas
MONTREAL and CHARLOTTE, N.C., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Na
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript
• Milestone Pharmaceuticals stock is taking a hit today. Why is MIST stock falling?
EU decision delay for Milestone Pharmaceuticals etripamil, despite strong U.S. launch progress, soli
Gainers
Monday saw 196 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday